Skip to main content
PLOS One logoLink to PLOS One
. 2023 Feb 24;18(2):e0280868. doi: 10.1371/journal.pone.0280868

Metabolomics of developmental changes in Triatoma sanguisuga gut microbiota

Evan Teal 1, Claudia Herrera 1, Eric Dumonteil 1,*
Editor: Yara M Traub-Csekö2
PMCID: PMC9955940  PMID: 36827319

Abstract

Triatoma sanguisuga is one of the major vectors of Trypanosoma cruzi in the southeastern US, where it sustains a robust zoonotic parasite transmission cycle and occasional human infections. A better understanding of triatomine development may allow for alternative approaches to insecticide-based vector control. Indeed, the role of the gut microbiota and bacterial endosymbionts in triatomine development and in their vectorial capacity is emerging. We investigated here the differences in microbiota among nymph and adult T. sanguisuga, to shed light on the metabolomic interactions occurring during development. Microbiota composition was assessed by 16s gene amplification and deep sequencing from field-caught adult bugs and their laboratory-raised progeny. Significant differences in microbiota bacterial diversity and composition were observed between nymphs and adults. Laboratory-raised nymphs showed a higher taxonomic diversity, and at least seven families predominated. On the other hand, field-caught adults had a lower bacterial diversity and four families comprised most of the microbiota. These differences in compositions were associated with differences in predicted metabolism, with laboratory-raised nymphs microbiota metabolizing a limited diversity of carbon sources, with potential for resource competition between bacterial families, and the production of lactic acid as a predominant fermentation product. On the other hand, field-caught adult microbiota was predicted to metabolize a broader diversity of carbon sources, with complementarity rather than competition among taxa, and produced a diverse range of products in a more balanced manner. The restricted functionality of laboratory-raised nymph microbiota may be associated with their poor development in captivity, and further understanding of the metabolic interactions at play may lead to alternative vector control strategies targeting triatomine microbiota.

Introduction

Chagas disease is a parasitic illness which afflicts 6–8 million people in Latin America alone [1], and an estimated 288,000 people in the United States [2]. It is caused by Trypanosoma cruzi parasites, which are transmitted primarily by triatomine insect vectors, although additional transmission routes contribute to disease epidemiology. At least 11 triatomine species can transmit T. cruzi in the United States, with Triatoma sanguisuga the most relevant species in the southeastern part of the country [3]. It is responsible for an active zoonotic parasite transmission cycle involving multiple sylvatic and synanthropic mammalian hosts, with frequent spill-over in domestic animals including pet dogs and cats [47], and occasional cases of autochthonous human cases, as seen in Mississippi [8], Tennessee [9] and Louisiana [10].

Vector control conventionally relies on residual insecticide spraying, which shows limitation in the case of intrusive sylvatic vectors [11], and alternative approaches are critically needed. In that sense, triatomine gut microbiota and the key contribution of specific bacterial endosymbionts to bug development and to its vectorial capacity are emerging as attractive targets for novels strategies. For example, the successful development of Rhodnius prolixus, one of the most epidemiologically relevant vector species in large parts of South America [12, 13], is thought to be critically dependent on the provision of B-complex vitamins by its endosymbiont Rhodococcus rhodnii, which is acquired during bug development through coprophagy [14]. Thus, vitamin B deficiency in laboratory colonies leads to growth retardation and nymphs fail to reach the adult stage in the absence of R. rhodnii, although a more recent study suggests that additional bacteria in the gut microbiota may also contribute to vitamin B production [15]. Furthermore, other studies suggest that the microbiota is likely providing multiple metabolites in addition to vitamin B [16].

In spite of these studies, our understanding of the contribution of the microbiota to triatomine development remains limited. A general trend in field-caught bugs is that nymphs have a highly diverse microbiota, which often differs from that of adult bugs, suggesting different metabolic functions and interactions. This is the case for Triatoma protracta [17], Triatoma reticularia [17], Triatoma rubida [17], Triatoma dimidiata [18, 19], and Rhodnius prolixus [20]. On the other hand, in Triatoma sordida the adult microbiota is more diverse compared to nymphs, with unique bacteria being incorporated from the 4th instar stage onwards [21]. Furthermore, it is still unclear how such changes in microbiota composition may translate into differences in metabolic profiles and interactions among bacteria and the bugs. In T. sanguisuga, too limited data is available to assess changes in microbiota during development [17], but this species is notoriously difficult to raise in captivity as nymphs mostly stop molting in the third instar stage and die [22, 23]. This has been associated with the requirement of maintaining nymphs together with field-collected adults, under the hypothesis that this allowed them to acquire necessary flora through coprophagy [23].

The gut microbiota also likely interacts with T. cruzi parasites as these reside in the triatomine gut, and the microbiota may modulate vectorial capacity as bacteria and parasite compete for metabolites and may inhibit one another. For example Serratia marcescens, another member of R. prolixus microbiota, has a trypanolytic activity that can antagonize T. cruzi growth [24, 25]. In fact, T. cruzi infection leads to changes in microbiota composition in several triatomine species, suggesting tight interactions among bacteria and the parasite [2629]. These interactions may also be highly parasite strain-specific, as some differences in microbiota composition were detected according to T. cruzi parasite DTU present in T. sanguisuga [4] and T. dimidiata [29]. The introduction of transgenic organisms into the microbiota of triatomine vectors through various strategies has been proposed before as a potential approach to promote the production of trypanolytic factors by endosymbionts to reduce T. cruzi establishment in vectors, hence reducing vector capacity [30, 31], and a better understanding on microbiota functions may lead to effective targets.

Because T. sanguisuga may be an interesting model to better evaluate the role of the microbiota in triatomine development, we sought to assess potential differences in microbiota between nymphs and adults, to test the hypothesis that laboratory-raised nymphs lack key bacteria compared to field-collected adults [23]. We further predict key functional metabolic properties of the identified microbiota as a first step towards evaluating microbiota metabolic functions in T. sanguisuga.

Materials and methods

Triatomines and DNA extraction

Insects were collected across Louisiana, USA, through community participation, in the years 2019 and 2021, and brought to an biosafety level 2 facility for diagnosis of T. cruzi in the insect feces via PCR. Uninfected adult females were kept individually in Nalgene containers with mesh lined tops and filter paper folds to lay eggs. Bugs were fed every 2–3 weeks via bell feeder using sheep blood. Eggs and hatched nymphs were kept in the same containers with the adults. All nymphs failed to molt past the third instar stage and died. All bugs were collected and stored at -20ºC until used. A total of 23 insects were used: 18 nymphs (8 first instar, 6 second instar, and 4 third instar) and 5 female adults. For adults, DNA was extracted from the distal section of insect abdomens using a sterile disposable scalpel cleaned with dilute bleach, whereas for nymph the entire insect was used. DNA was extracted using the Qiagen DNEasy blood and tissue extraction kit following manufacturer’s instructions.

16s RNA gene amplification and sequencing

The full-length 16s RNA gene (about 1500 bp) was amplified using Oxford Nanopore 16s Barcoding kit (SQKRAB204) following the manufacturer’s instructions except that two rounds of PCR amplification were performed for library preparation. DNA libraries were sequenced on a Nanopore MinIon platform. Raw sequence data are available in the NCBI SRA database under BioProject PRJNA892946, BioSamples SAMN31403430-.SAMN31403445.

Sequence and data analysis

Fastq DNA sequences were filtered for quality and length and analyzed with a Bayesian classifier from the Ribosomal Database Project [32] as implemented in Geneious Prime. We used a threshold of ≥97% sequence identity for taxonomic identification of bacterial taxa at the family level. Microbiota composition was then analyzed using MicrobiomeAnalyst [33, 34]. Data were first rarefied and normalized using the Total Sum Scaling (TSS) method, to account for variability in sequencing depth. Chao1 and Shannon alpha diversity indices were calculated and compared between groups using t-tests. For beta diversity, Non-Metric Dimensional Scaling (NMDS) was used based on Bray-Curtis distances and statistical significance of differences was assessed by Permutational ANOVA (PERMANOVA). Associations of individual bacterial families with triatomine developmental stage were assessed by correlation analysis. A co-occurrence network of bacterial families based on SparCC correlations was also constructed to identify bacteria which presence/absence are strongly correlated within a specific developmental stage of T. sanguisuga. FDR corrections were used to account for multiple testing in establishing the statistical significance of the associations.

For metabolic analysis, the AGORA database from the Virtual Metabolic Human was used, which provides metabolic reconstruction of over 800 bacterial species from microbiomes [35]. Carbon sources and fermentation products associated with the most abundant bacterial families identified in T. sanguisuga were extracted and weighted based of the proportion of species within each family able to use/produce each metabolite. Seven bacterial families were included for nymphs, and four for adults, which accounted for over 85% of the microbiota for each group. The relative level of each metabolite used/produced by each bacterial family was calculated based on their relative abundance in the microbiota, to establish the predicted integrated metabolic profile of the bacterial community.

Results

Microbiota composition of nymph and adult T. sanguisuga

A total of 23 bugs were included in the study, but data from seven first instars were discarded from the analysis due to poor DNA extraction, 16s amplification or sequencing. The remaining 16 samples yielded an average of 80,947 reads per bug. After filtering and normalization, rarefaction curves indicated that this sequencing amount was sufficient to recover most of the bacterial diversity of these samples (S1 Fig). An initial comparison of second and third instar microbiota composition indicated that their alpha and beta diversity were not significantly different (S2 Fig), and these were combined into a single nymph group for further comparison with adult microbiota.

Comparison of alpha diversity between T. sanguisuga laboratory-raised nymph and field-caught adult microbiota indicated that nymphs harbored a greater diversity of bacterial families than adults, as indicated by Shannon and Chao1 indices, although the later did not reach statistical significance (Fig 1A and 1B, t = 2.88, P = 0.017 and t = 0.29, P = 0.78, respectively). Indeed, laboratory-raised nymph’s microbiota included up to 14 bacterial families, while only 10 were detected in field-caught adults (Fig 1C). Seven taxa comprised over 85% of the laboratory-raised nymph microbiota, including Xanthomonadaceae, Moraxellaceae, Clostridales incertae sedis, Propionibacteriaceae, Staphylococcaceae, Burkholderiales incertae sedis and Aerococcaceae, while the field-caught adult microbiota included four predominant taxa: Enterobacteriaceae, Porphyromonadaceae, Staphylococcaceae and Peptoniphilaceae. Analysis of beta diversity confirmed that there was a significant difference in microbiota composition between nymph and adult bugs (Fig 2, F = 4.2; R2 = 0.23; P = 0.002).

Fig 1. Diversity of T. sanguisuga microbiota during development.

Fig 1

Box plots and individual values of alpha diversity expressed as Shannon (A) and Chao1 indices (B) were compared for laboratory-raised nymphs and field-caught adults. Nymphs presented a significantly higher Shannon index compared to adults (t = 2.88, P = 0.017), but the difference in Chao1 index did not reach statistical significance (t = 0.29, P = 0.78). (C) Bacterial composition of laboratory-raised nymph and field-caught adult microbiota. Taxonomic groups are color-coded as indicated.

Fig 2. Beta diversity of T. sanguisuga microbiota.

Fig 2

The beta diversity was compared between laboratory-raised nymphs and field-caught adults through NMDS analysis, which showed a statistically significant difference in taxonomic composition of the microbiota (PERMANOVA, F = 4.2; R2 = 0.23; P = 0.002). Points indicate individual bugs, and 95% elipses are shown for each group.

Four families rather abundantly present in laboratory-raised nymphs were absent in field-caught adults (Burkholderiales incertae sedis, Carnobacteriaceae, Comamonadaceae and Moraxellaceae), and an additional six families present in both nymphs and adults were strongly decreased in adults (Aerococcaceae, Burkholderiaceae, Clostridales incertae sedis, Propionibacteriaceae, Streptococcaceae and Xanthomonadaceae). On the other hand, Enterobacteriaceae, Porphyromonadaceae, Staphylococcaceae, which were minor component of the laboratory-raised nymph microbiota, were strongly increased and predominated in the microbiota of field-caught adults.

Associations among bacterial families and developmental stage

To further assess which bacteria may associate with specific developmental stage, we performed correlation analysis. Peptoniphilaceae, Porphyromonadaceae and to a lesser extent Enterobacteriaceae were significantly associated with the field-caught adult microbiota, while Carnobacteriaceae, Clostridales incertae sedis, and Streptococcaceae were significantly associated with laboratory-raised nymph microbiota (Fig 3). Analysis of co-occurrence networks also indicated that several bacterial families were occurring simultaneously in a microbiota, suggesting functional interactions. For example, Peptoniphilaceae and Porphyromonadaceae were frequently found together in field-caught adults, while Propionibacteraceae and Clostridales insertae sedis co-occurred in laboratory-raised nymphs (Fig 4). Similarly, Moraxellaceae, Burkholderiales incertae sedis and Comamonadaceae co-occured in nymphs and may antagonize Staphylococcaceae which was more abundant in adults.

Fig 3. Correlation analysis of bacterial taxa with developmental stage.

Fig 3

The association of bacterial taxa with developmental stage was assessed by sparCC correlation. Peptoniphilaceae, Porphyromonadaceae and to a lesser extent Enterobacteriaceae were significantly correlated with the field-caught adult microbiota, while Carnobacteriaceae, Clostridales incertae sedis, and Streptococcaceae were significantly correlated with laboratory-raised nymph microbiota (P<0.05).

Fig 4. Co-occurrence network of bacterial taxa in T. sanguisuga.

Fig 4

The co-occurrence of bacterial taxa in the microbiota of laboratory-raised nymphs (Orange circle nodes) and field-caught adults (Green circle nodes) was evaluated by SparCC correlations. The correlation coefficient is indicated on the edge linking two taxa. The size of the nodes is proportional to the relative abundance of the taxa in the microbiota.

Metabolic function of T. sanguisuga microbiota

The contribution of the predominant bacterial families to the integrated microbiota metabolic functions was then predicted, based on the AGORA database [35]. We included metabolic functions from seven families in nymphs and four in adults, which represented over 85% of their respective microbiota. Bacteria from the laboratory-raised nymph microbiota used a limited variety of carbon sources, in which glucose largely predominated, and the use of the same carbon sources by multiple bacterial families suggested potential competition for these resources (Fig 5A). The fermentation products of the laboratory-raised nymph microbiota included mostly lactic and acetic acid, and a limited variety of additional compounds in lesser amounts (Fig 5B). On the other hand, the field-caught adult microbiota, in spite of comprising a limited diversity of bacteria, appeared able to process a broader diversity of carbon sources in a more balanced manner, even though glucose was also an important source (Fig 5C). Also, while the adult microbiota fermentation products included lactic and acetic acids, it was not as biased as that of laboratory-raised nymphs, and a larger diversity of compounds were also produced in more comparable relative amounts (Fig 5D). For example, indole, (2R,3R)-2,3-butanediol and phenylacetic acid were only produced by the adult microbiota. Together, these data point to important differences in metabolic functions of the microbiota between laboratory-raised nymphs and field-caught adults, with the microbiota from adults presenting potential functional gains in terms of metabolic properties.

Fig 5. Metabolic reconstruction of T. sanguisuga microbiota.

Fig 5

The relative abundance of carbon sources metabolized by nymph microbiota (A) is compared to those from the adult microbiota (B). Similarly, the relative amounts of fermentation products from the nymph microbiota (C) are compared with those from the adult microbiota (D). The relative contribution of the indicated bacterial taxa in the use/production of metabolites is color-coded as indicated.

Discussion

Triatomine gut microbiota is thought to play a key role in bug metabolism by providing key functions and metabolites to maximize the use of blood meals from these strict hematophagous bugs. However, the role of the microbiota in triatomine development remains poorly understood, in particular for T. sanguisuga, for which deficiencies in endosymbionts have been proposed to explain the poor survival of nymphs in captivity [23]. Our comparison of microbiota between laboratory-raised nymphs and field-caught adults provides initial support to this hypothesis and underlines metabolic differences that may explain the limited survival of nymphs in these conditions. Indeed, our data clearly show that there is no/limited vertical transmission of the field-caught adult microbiota to their laboratory-raised offspring, suggesting that nymphs nymphs need to acquire bacteria from their environment, and the ones they acquire under laboratory condition are insufficient for their development. Thus, the microbiota of T. sanguisuga seems to follow the general trend observed in other species of triatomines, with a more complex and diverse microbiota present in nymphs, while the adult microbiota is largely dominated by fewer taxa [17, 18, 20].

These data suggest a major reshuffle of the microbiota during development, with most taxa present in nymphs being replaced by a more limited set of taxa in adults, likely through coprophagy. However, at the functional level, the simpler adult microbiome of T. sanguisuga actually appears to provide a more complex metabolic network. The simplification of the microbiota in adults thus results in significant gains in metabolic functions. Indeed, the microbiota from laboratory-raised nymphs appears limited in its metabolic capabilities, with potential for competition among taxa, which may result in an unstable bacterial community of limited value to the bugs, leading to poor growth. On the other hand, the reduced complexity of the field-caught adult microbiota may allow for less competition, while at the same time ensuring a greater diversity of metabolic functions, which may better maximize the use of blood metabolites.

However, it remains difficult to assess what key metabolic function(s) is/are provided by the filed-caught adult microbiota that is/are absent in the laboratory-raised nymph microbiota based on our predicted data. In Rhodnius prolixus, the supplementation of blood with vitamin B compounds can in part compensate for the absence of Rhodococcus rhodnii endosymbionts in laboratory-raised bugs [36]. It is however unclear what key metabolic function Peptoniphilaceae, Porphyromonadaceae and Enterobacteriaceae, which predominate in adult T. sanguisuga, may be providing to the bug. However, given the magnitude of the differences in bacterial taxa between nymphs and adults, it is likely that these bacteria are involved in multiple metabolic functions.

Triatomines also emerge as rather different from other Hemiptera, which as hemimetabolous insects are considered to have a rather stable microbiota during development [37]. Indeed, a dramatic reorganization of the gut microbiota during development has been proposed as a key feature of holometabolous insects, due to the major internal reconstructions during the pupal stage, which includes the replacement of the gut epithelium, while this process does not occur in hemimetabolous insects [37]. In that sense, the strict blood feeding of triatomine likely poses unique metabolic challenges, that may require more specific functions from their microbiota, hence more changes during bug development, which may be unique among Hemiptera and more generally in hemimetabolous insects.

There are however some limitations in our study. First, our limited sample size and the failure of bugs to molt past the third stage precluded an analysis through all laboratory-raised nymphal stages and adults, as changes may be progressive as seen in R. prolixus [20], or more rapid. Also, only female adults were included, but previous work did not find significant differences between male and female microbiota in T. sanguisuga [4]. The inclusion of field-collected T. sanguisuga nymphs would also expand our analysis by providing further information on how these changes in microbiota occur in natural conditions. Finally, further refinement of the microbiota at the species level would allow for more detailed metabolic predictions, as there is some heterogeneity in metabolic routes within bacterial families. Also, dissecting and analyzing different segments of the digestive tract of the bugs would allow further assessing potential differences in microbiota composition along the gut and the role of metabolic compartmentalization.

In conclusion, our study shows that T. sanguisuga nymphs with developmental failure have a diverse but metabolically limited microbiota, very different from that of field-collected adults. The adult microbiota, while including a lower bacterial diversity, provides a broader metabolic capacity that may be better suited to triatomine blood feeding diet. Further analysis, including of additional triatomine species, is warranted, as well as more detailed metabolic reconstructions of their microbiota for a better understanding of its role in triatomine biology and development.

Supporting information

S1 Fig. Rarefaction curves for individual samples.

Curves indicate adequate sequencing depth for samples included in the analysis.

(TIF)

S2 Fig. Comparison of alfa and beta diversity of second and third stage nymphs.

For alpha diversity, there was no significant difference in Shannon (t = 0.45, P = 0.65) and Chao1 indices (t = 1.34, P = 0.21) between second (N2) and third stage nymphs (N3). Beta diversity was also not different between N2 and N3 (PERMANOVA, F = 1.9; P = 0.09).

(TIF)

Data Availability

Raw sequence data are available in the NCBI SRA database under BioProject PRJNA892946, BioSamples SAMN31403430-.SAMN31403445.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.WHO. Chagas disease in Latin America: an epidemiological update based on 2010 estimates. Weekly Epidemiol Record. 2015;90(6):33–43. [PubMed] [Google Scholar]
  • 2.Irish A, Whitman JD, Clark EH, Marcus R, Bern C. Updated Estimates and Mapping for Prevalence of Chagas Disease among Adults, United States. Emerg Infect Dis. 2022;28(7):1313–20. doi: 10.3201/eid2807.212221 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Bern C, Messenger LA, Whitman JD, Maguire JH. Chagas Disease in the United States: a Public Health Approach. Clin Microbiol Rev. 2019;33(1). doi: 10.1128/CMR.00023-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Dumonteil E, Pronovost H, Bierman EF, Sanford A, Majeau A, Moore R, et al. Interactions among Triatoma sanguisuga blood feeding sources, gut microbiota and Trypanosoma cruzi diversity in southern Louisiana. Mol Ecol. 2020;29(19):3747–61. [DOI] [PubMed] [Google Scholar]
  • 5.Elmayan A, Tu W, Duhon B, Marx P, Wolfson W, Balsamo G, et al. High prevalence of Trypanosoma cruzi infection in shelter dogs from southern Louisiana, USA. Parasites & vectors. 2019;12:322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Dumonteil E, Elmayan A, Majeau A, Tu W, Duhon B, Marx P, et al. Genetic diversity of Trypanosoma cruzi parasites infecting dogs in southern Louisiana sheds light on parasite transmission cycles and serological diagnostic performance. PLoS Negl Trop Dis. 2020;14(12):e0008932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Dumonteil E, Desale H, Tu W, Duhon B, Wolfson W, Balsamo G, et al. Shelter cats host infections with multiple Trypanosoma cruzi discrete typing units in southern Louisiana. Vet Res. 2021;52(1):53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Cantey PT, Stramer SL, Townsend RL, Kamel H, Ofafa K, Todd CW, et al. The United States Trypanosoma cruzi Infection Study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors. Transfusion. 2012;52(9):1922–30. [DOI] [PubMed] [Google Scholar]
  • 9.Herwaldt BL, Grijalva MJ, Newsome AL, McGhee CR, Powell MR, Nemec DG, et al. Use of Polymerase Chain Reaction to Diagnose the Fifth Reported US Case of Autochthonous Transmission of Trypanosoma cruzi, in Tennessee, 1998. J Infect Dis. 2000;181:395–9. [DOI] [PubMed] [Google Scholar]
  • 10.Dorn PL, Perniciaro L, Yabsley MJ, Roellig DM, Balsamo G, Diaz J, et al. Autochthonous transmission of Trypanosoma cruzi, Louisiana. Emerg Infect Dis. 2007;13(4):605–7. doi: 10.3201/eid1304.061002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Waleckx E, Gourbière S, Dumonteil E. Intrusive triatomines and the challenge of adapting vector control practices. Mem Inst Oswaldo Cruz. 2015;110(3):324–38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Dias JC, Silveira AC, Schofield CJ. The impact of Chagas disease control in Latin America: a review. Mem Inst Oswaldo Cruz. 2002;97(5):603–12. doi: 10.1590/s0074-02762002000500002 [DOI] [PubMed] [Google Scholar]
  • 13.Gourbière S, Dorn P, Tripet F, Dumonteil E. Genetics and evolution of triatomines: from phylogeny to vector control. Heredity. 2012;108:190–202. doi: 10.1038/hdy.2011.71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Harington JS. Synthesis of thiamine and folic acid by Nocardia rhodnii, the micro-symbiont of Rhodnius prolixus. Nature. 1960;188:1027–8. doi: 10.1038/1881027a0 [DOI] [PubMed] [Google Scholar]
  • 15.Tobias NJ, Eberhard FE, Guarneri AA. Enzymatic biosynthesis of B-complex vitamins is supplied by diverse microbiota in the Rhodnius prolixus anterior midgut following Trypanosoma cruzi infection. Comput Struct Biotechnol J. 2020;18:3395–401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Hill P, Campbell JA, Petrie IA. Rhodnius prolixus and its symbiotic actinomycete: a microbiological, physiological and behavioural study. Proc R Soc Lond B Biol Sci. 1976;194(1117):501–25. doi: 10.1098/rspb.1976.0091 [DOI] [PubMed] [Google Scholar]
  • 17.Brown JJ, Rodriguez-Ruano SM, Poosakkannu A, Batani G, Schmidt JO, Roachell W, et al. Ontogeny, species identity, and environment dominate microbiome dynamics in wild populations of kissing bugs (Triatominae). Microbiome. 2020;8(1):146. doi: 10.1186/s40168-020-00921-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Murillo-Solano C, Lopez-Dominguez J, Gongora R, Rojas-Gulloso A, Usme-Ciro J, Perdomo-Balaguera E, et al. Diversity and interactions among triatomine bugs, their blood feeding sources, gut microbiota and Trypanosoma cruzi in the Sierra Nevada de Santa Marta in Colombia. Sci Rep. 2021;11(1):12306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Polonio R, Lopez-Dominguez J, Herrera C, Dumonteil E. Molecular ecology of Triatoma dimidiata in southern Belize reveals risk for human infection and the local differentiation of Trypanosoma cruzi parasites. Int J Infect Dis. 2021;108:320–9. [DOI] [PubMed] [Google Scholar]
  • 20.Rodriguez-Ruano SM, Skochova V, Rego ROM, Schmidt JO, Roachell W, Hypsa V, et al. Microbiomes of North American Triatominae: The Grounds for Chagas Disease Epidemiology. Front Microbiol. 2018;9:1167. doi: 10.3389/fmicb.2018.01167 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Oliveira JL, Cury JC, Gurgel-Goncalves R, Bahia AC, Monteiro FA. Field-collected Triatoma sordida from central Brazil display high microbiota diversity that varies with regard to developmental stage and intestinal segmentation. PLoS Negl Trop Dis. 2018;12(8):e0006709. doi: 10.1371/journal.pntd.0006709 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Pippin WF. The biology and vector capability of Triatoma sanguisuga texana usinger and Triatoma gerstaeckeri (Stal) compared with Rhodnius prolixus (Stal) (Hemiptera: Triatominae). J Med Entomol. 1970;7(1):30–45. [DOI] [PubMed] [Google Scholar]
  • 23.Hays KL. Longevity, fecundity, and food intake of adult Triatoma sanguisuga (Leconte) (Hemiptera: Triatominae). J Med Entomol. 1965;2(2):200–2. [DOI] [PubMed] [Google Scholar]
  • 24.Azambuja P, Feder D, Garcia ES. Isolation of Serratia marcescens in the midgut of Rhodnius prolixus: impact on the establishment of the parasite Trypanosoma cruzi in the vector. Exp Parasitol. 2004;107(1–2):89–96. doi: 10.1016/j.exppara.2004.04.007 [DOI] [PubMed] [Google Scholar]
  • 25.Castro DP, Seabra SH, Garcia ES, de Souza W, Azambuja P. Trypanosoma cruzi: ultrastructural studies of adhesion, lysis and biofilm formation by Serratia marcescens. Exp Parasitol. 2007;117(2):201–7. doi: 10.1016/j.exppara.2007.04.014 [DOI] [PubMed] [Google Scholar]
  • 26.Garcia ES, Genta FA, de Azambuja P, Schaub GA. Interactions between intestinal compounds of triatomines and Trypanosoma cruzi. Trends Parasitol. 2010;26(10):499–505. doi: 10.1016/j.pt.2010.07.003 [DOI] [PubMed] [Google Scholar]
  • 27.Diaz S, Villavicencio B, Correia N, Costa J, Haag KL. Triatomine bugs, their microbiota and Trypanosoma cruzi: asymmetric responses of bacteria to an infected blood meal. Parasites & vectors. 2016;9(1):636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Eberhard FE, Klimpel S, Guarneri AA, Tobias NJ. Exposure to Trypanosoma parasites induces changes in the microbiome of the Chagas disease vector Rhodnius prolixus. Microbiome. 2022;10(1):45. doi: 10.1186/s40168-022-01240-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Murillo-Solano C, Ramos-Ligonio A, Lopez-Monteon A, Guzman-Gomez D, Torres-Montero J, Herrera C, et al. Diversity of Trypanosoma cruzi parasites infecting Triatoma dimidiata in Central Veracruz, Mexico, and their One Health ecological interactions. Infect Genet Evol. 2021;95:105050. doi: 10.1016/j.meegid.2021.105050 [DOI] [PubMed] [Google Scholar]
  • 30.Beard CB, Durvasula RV, Richards FF. Bacterial symbiosis in arthopods and the control of disease transmission. Emerging infectious diseases. 1998;4:581–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Hurwitz I, Fieck A, Read A, Hillesland H, Klein N, Kang A, et al. Paratransgenic control of vector borne diseases. Int J Biol Sci. 2011;7(9):1334–44. doi: 10.7150/ijbs.7.1334 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Cole JR, Wang Q, Fish JA, Chai B, McGarrell DM, Sun Y, et al. Ribosomal Database Project: data and tools for high throughput rRNA analysis. Nucl Acids Res. 2014;42(Database issue):D633–42. doi: 10.1093/nar/gkt1244 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Dhariwal A, Chong J, Habib S, King IL, Agellon LB, Xia J. MicrobiomeAnalyst: a web-based tool for comprehensive statistical, visual and meta-analysis of microbiome data. Nucl Acids Res. 2017;45(W1):W180–W8. doi: 10.1093/nar/gkx295 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Chong J, Liu P, Zhou G, Xia J. Using MicrobiomeAnalyst for comprehensive statistical, functional, and meta-analysis of microbiome data. Nat Protoc. 2020;15(3):799–821. doi: 10.1038/s41596-019-0264-1 [DOI] [PubMed] [Google Scholar]
  • 35.Magnusdottir S, Heinken A, Kutt L, Ravcheev DA, Bauer E, Noronha A, et al. Generation of genome-scale metabolic reconstructions for 773 members of the human gut microbiota. Nat Biotechnol. 2017;35(1):81–9. doi: 10.1038/nbt.3703 [DOI] [PubMed] [Google Scholar]
  • 36.Lake P, Friend WG. The use of artificial diets to determine some of the effects of Nocardia rhodnii on the development of Rhodnius prolixus. J Insect Physiol. 1968;14(4):543–62. [DOI] [PubMed] [Google Scholar]
  • 37.Manthey C, Johnston PR, Nakagawa S, Rolff J. Complete metamorphosis and microbiota turnover in insects. Mol Ecol. 2022. in press. doi: 10.1111/mec.16673 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Yara M Traub-Csekö

14 Dec 2022

PONE-D-22-29767Metabolomics of developmental changes in Triatoma sanguisuga gut microbiotaPLOS ONE

Dear Dr. Dumonteil,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jan 28 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Yara M. Traub-Csekö

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear colleagues,

Identifying microbial diversity in Triatoma sanguisuga is interesting and adds important information to the adaptation scenario between wild-caught and laboratory-reared insects. The manuscript is well-written and can contribute to several other entomology research laboratories.

Nevertheless, a few aspects need to be clarified. Therefore, I hope my comments will help to improve the clarity of some aspects of the manuscript.

Major comments

The authors used two insect groups, one composed of field-caught adults and another group composed of their offspring reared under laboratory conditions, for analyzing the microbial diversity in the insect gut. I understand that rearing adults in the laboratory was not possible; therefore, nymphs were used in the analyses. Throughout the text, authors refer to these groups as nymphs and adults, reflecting differences in microbial diversity between the developmental stages of T. sanguisuga. Nevertheless, to address the difference between insect stages, authors should have compared nymphs and adults reared under the same conditions.

I presume that under the current experimental design, the changes in microbial diversity between wild-caught adults and laboratory-reared nymphs were likely caused by the adaptation to the laboratory conditions. This aspect needs to be clarified throughout the manuscript, including the title.

The authors sequenced the bacterial 16S ribosomal gene to identify the microbial diversity and consequently predict the metabolome. Therefore, it is an indirect finding. It also needs to let clearer in the manuscript.

Minor comments

I suggest using abbreviations like “field-caught adults (FCA) and laboratory-reared nymphs (LRN)” to avoid misunderstanding the comparison between the two insect groups. The way it is written throughout the manuscript, referring to nymphs and adults, may be misleading.

Line 54: citation number 8 does not match the references list.

Lines 73 and 74; 77 and 78: The context in this paragraph is the comparison between nymphs and adults. This comparison is possible if both stages are reared under the same conditions, evidencing that the changes occur through the development of the insects. Were authors aiming to use the same context in their analyses?

Line 104: The term “endosymbionts” must be checked if it is adequate here and throughout the manuscript. It is common that gut bacteria are referred to as endosymbionts, but not all of them can be clearly proven. Some of them are commensal, and others are opportunistic. In addition, several endosymbionts are intracellular and maternally transmitted. They have a lower probability of being lost across developmental stages.

Lines 149 to 151: In the present study, authors identified bacteria at the family level and deduced the metabolic reconstruction based on the association to a set of bacteria species available in the AGORA database. How often does a given bacterium share the same metabolic reconstruction with others from the same family? It is important to address the level of confidence in this association.

Discretionary comments

Line 111: Full name of “ASL2” was missed when used for the first time in the text.

Line 215: Would it be “variety” instead of “varied”?

Reviewer #2: Observations:

Line -25: I believe that instead of "alterative approaches" the authors mean "alternative approaches". Please fix it.

Line 54: it is spelled zoootic, but the correct one is zoonotic. please fix this

Line 55: change “synantropic” by “synanthropic”.

Line 56: the word “ authchtonous” is misspelled, change to the correct form “ autochthonous”.

Line 96: In the sentence “The paratransgenesis of triatomine microbiota …”, the authors are mistaken in relation to the concept of paratransgenic organism. It is not the microbiota that undergoes the paratransgenic process, but the vector in question. The microbiota of this vector undergoes a transgenic process. Who is paratransgenic is the vector, the modified microbiota is transgenic. I suggest changing the sentence to something like: "...the paratransgenic of triatomine vectors..." or "...the introduction of transgenic organisms into the microbiota of triatomine vectors..."

Lane 98: The word “edosymbonts” is misspelled, change to correct form “endosymbionts”.

Line 117: There is a mistake here, the sum of the number of nymphs in each stage (8+6+4) is 18 and not 11. Please fix it.

Line 136: “Micriobiota” is the misspelled form of “microbiota”. Please fix it.

Line 143: The singular verb was does not appear to agree with the plural subject Associations. Consider changing the verb form to were for subject-verb agreement.

Line 52: “… extracted, and weighted..” It appears that you have an unnecessary comma in a compound predicate. Consider removing it.

Line 215: The word varied doesn’t seem to fit this context. Consider replacing it with Variety

Line 231: ”… the role to the microbiota …” It seems that preposition use may be incorrect here. Consider change to of.

Line 277: the word occurr is a misspelling of occur. Fix it.

Figures:

The figures 3 and 4 are with the subtitles changed. Fix it.

Materials and methods:

To obtain the DNA to be used in the identification of the microbiota bacteria of T. sanguisuga. The authors used a section of the abdomen of adult insects and the entire body of nymphs. This generates noise, as in the case of nymphs bacteria that do not belong to the intestinal microbiota may be being counted as if they were. Ideally, material from nymphs and adults should be obtained through dissection of the intestines of both.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Antonio J Tempone

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Feb 24;18(2):e0280868. doi: 10.1371/journal.pone.0280868.r002

Author response to Decision Letter 0


28 Dec 2022

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Partly

ANSWER: We thank the reviewers for their comments and have addressed these in detail below.

________________________________________

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

ANSWER: We thank the reviewers for their comments.

________________________________________

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

ANSWER: We thank the reviewers for their comments.

________________________________________

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

ANSWER: We thank the reviewers for their comments.

________________________________________

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear colleagues,

Identifying microbial diversity in Triatoma sanguisuga is interesting and adds important information to the adaptation scenario between wild-caught and laboratory-reared insects. The manuscript is well-written and can contribute to several other entomology research laboratories.

Nevertheless, a few aspects need to be clarified. Therefore, I hope my comments will help to improve the clarity of some aspects of the manuscript.

ANSWER: We thank the reviewer for their appreciation of our study and detail below how we have addressed the specific points raised.

Major comments

The authors used two insect groups, one composed of field-caught adults and another group composed of their offspring reared under laboratory conditions, for analyzing the microbial diversity in the insect gut. I understand that rearing adults in the laboratory was not possible; therefore, nymphs were used in the analyses. Throughout the text, authors refer to these groups as nymphs and adults, reflecting differences in microbial diversity between the developmental stages of T. sanguisuga. Nevertheless, to address the difference between insect stages, authors should have compared nymphs and adults reared under the same conditions.

I presume that under the current experimental design, the changes in microbial diversity between wild-caught adults and laboratory-reared nymphs were likely caused by the adaptation to the laboratory conditions. This aspect needs to be clarified throughout the manuscript, including the title.

ANSWER: We agree with the reviewer that we compare the microbiota of field-caught adults with that of their offspring reared under laboratory conditions, and it is indeed likely that laboratory conditions play a role in defining microbial composition in these bugs. Nonetheless, we clearly stated that our hypothesis was that “laboratory-raised nymphs lack key bacteria compared to field-collected adults”, which may help explain their failure to develop adequately in laboratory colonies. This comparison shows that there is no/limited vertical transmission of the field-caught adult microbiota to their lab-raised offspring, as we found that young (lab-raised) nymphs have a different microbiota from their (field-caught) parents. These data clearly indicate that nymphs need to acquire bacteria from their environment, and the ones they acquire under laboratory condition are insufficient for their development. These considerations have been added to the discussion for greater clarity (Page 10, lines 256-259). We also specifically mention as limitations of our study that “the failure of bugs to molt past the third stage precluded an analysis through all laboratory-raised nymphal stages and adults”, and that “the inclusion of field-collected T. sanguisuga nymphs would expand our analysis by providing further information on how these changes in microbiota occur in natural conditions.” (Page 12, lines 297-299, lines 301-303).

The authors sequenced the bacterial 16S ribosomal gene to identify the microbial diversity and consequently predict the metabolome. Therefore, it is an indirect finding. It also needs to let clearer in the manuscript.

ANSWER: We agree with the reviewer that the analysis of the metabolome is predicted from the microbiota composition, this is now better stressed in multiple sections of the manuscript for greater clarity (Abstract line 36; Page 5, Line 111; Page 7, line 171; Page 9, line 226; page 11, line 278; and page 12, line 304).

Minor comments

I suggest using abbreviations like “field-caught adults (FCA) and laboratory-reared nymphs (LRN)” to avoid misunderstanding the comparison between the two insect groups. The way it is written throughout the manuscript, referring to nymphs and adults, may be misleading.

ANSWER: We agree with the reviewer that referring to field-caught adults and laboratory-reared nymphs is much more accurate than just adults and nymphs, and the manuscript has been edited accordingly for greater clarity. Note that we nonetheless prefer not to use the non-standard abbreviation proposed, to ensure that the manuscript remains easy to read for a general readership.

Line 54: citation number 8 does not match the references list.

ANSWER: The reference has been corrected.

Lines 73 and 74; 77 and 78: The context in this paragraph is the comparison between nymphs and adults. This comparison is possible if both stages are reared under the same conditions, evidencing that the changes occur through the development of the insects. Were authors aiming to use the same context in their analyses?

ANSWER: This paragraph summarizes the main findings from studies based on field-collected nymphs and adults from several species. This is now specified for greater clarity (Page 4, Line 80). These studies do suggest changes in microbiota during development from nymphs to adults, although rearing conditions were uncontrolled as these are field-caught bugs.

Line 104: The term “endosymbionts” must be checked if it is adequate here and throughout the manuscript. It is common that gut bacteria are referred to as endosymbionts, but not all of them can be clearly proven. Some of them are commensal, and others are opportunistic. In addition, several endosymbionts are intracellular and maternally transmitted. They have a lower probability of being lost across developmental stages.

ANSWER: We agree with the reviewer and have reworded this sentence to mention “bacteria” instead of “endosymbiont”.

Lines 149 to 151: In the present study, authors identified bacteria at the family level and deduced the metabolic reconstruction based on the association to a set of bacteria species available in the AGORA database. How often does a given bacterium share the same metabolic reconstruction with others from the same family? It is important to address the level of confidence in this association.

ANSWER: There is indeed some heterogeneity in metabolic routes within bacterial families, particularly with families including multiple genera and species, which we took into account by weighting metabolites based of the proportion of species within each family able to use/produce each metabolite. We now mention that “further refinement of the microbiota at the species level would allow for more detailed metabolic predictions” (Page 12, lines 303-305).

Discretionary comments

Line 111: Full name of “ASL2” was missed when used for the first time in the text.

ANSWER: This abbreviation has been removed for clarity.

Line 215: Would it be “variety” instead of “varied”?

ANSWER: Yes, wording has been changed as suggested.

Reviewer #2: Observations:

Line -25: I believe that instead of "alterative approaches" the authors mean "alternative approaches". Please fix it.

ANSWER: This is correct, spelling has been corrected.

Line 54: it is spelled zoootic, but the correct one is zoonotic. please fix this

ANSWER: Spelling has been corrected.

Line 55: change “synantropic” by “synanthropic”.

ANSWER: Spelling has been corrected.

Line 56: the word “ authchtonous” is misspelled, change to the correct form “ autochthonous”.

ANSWER: Spelling has been corrected.

Line 96: In the sentence “The paratransgenesis of triatomine microbiota …”, the authors are mistaken in relation to the concept of paratransgenic organism. It is not the microbiota that undergoes the paratransgenic process, but the vector in question. The microbiota of this vector undergoes a transgenic process. Who is paratransgenic is the vector, the modified microbiota is transgenic. I suggest changing the sentence to something like: "...the paratransgenic of triatomine vectors..." or "...the introduction of transgenic organisms into the microbiota of triatomine vectors..."

ANSWER: We agree with the reviewer and have edited this sentence accordingly.

Lane 98: The word “edosymbonts” is misspelled, change to correct form “endosymbionts”.

ANSWER: Spelling has been corrected.

Line 117: There is a mistake here, the sum of the number of nymphs in each stage (8+6+4) is 18 and not 11. Please fix it.

ANSWER: The number has been corrected.

Line 136: “Micriobiota” is the misspelled form of “microbiota”. Please fix it.

ANSWER: Spelling has been corrected.

Line 143: The singular verb was does not appear to agree with the plural subject Associations. Consider changing the verb form to were for subject-verb agreement.

ANSWER: Spelling has been corrected.

Line 52: “… extracted, and weighted..” It appears that you have an unnecessary comma in a compound predicate. Consider removing it.

ANSWER: The coma has been removed.

Line 215: The word varied doesn’t seem to fit this context. Consider replacing it with Variety

ANSWER: Spelling has been corrected.

Line 231: ”… the role to the microbiota …” It seems that preposition use may be incorrect here. Consider change to of.

ANSWER: Wording has been corrected as suggested.

Line 277: the word occurr is a misspelling of occur. Fix it.

ANSWER: Spelling has been corrected.

Figures:

The figures 3 and 4 are with the subtitles changed. Fix it.

ANSWER: The figure legends are correct, but figure 3 and 4 were swapped, and they have now been renumbered.

Materials and methods:

To obtain the DNA to be used in the identification of the microbiota bacteria of T. sanguisuga. The authors used a section of the abdomen of adult insects and the entire body of nymphs. This generates noise, as in the case of nymphs bacteria that do not belong to the intestinal microbiota may be being counted as if they were. Ideally, material from nymphs and adults should be obtained through dissection of the intestines of both.

ANSWER: We agree with the reviewer that the inclusion of non-gut bacteria may have occurred, but this bias would be similar for both adult and nymphs as both samples included some other tissues and external cuticle. Such bias is also likely small as most bacterial families identified were anaerobic bacteria unlikely to derive from non-gut sources. We nonetheless added to the discussion that “dissecting and analyzing different segments of the digestive tract of the bugs would allow further assessing potential differences in microbiota composition along the gut and the role of metabolic compartmentalization” (Page 12, lines 305-308).

Attachment

Submitted filename: Answers to reviewers.docx

Decision Letter 1

Yara M Traub-Csekö

11 Jan 2023

Metabolomics of developmental changes in Triatoma sanguisuga gut microbiota

PONE-D-22-29767R1

Dear Dr. Dumonteil,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Yara M. Traub-Csekö

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear colleagues,

The page and line numbers cited in the authors' answers were not matching with the new submitted version. Nevertheless, the corresponding changes could be found.

All questions and comments were addressed.

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Antonio J Tempone

**********

Acceptance letter

Yara M Traub-Csekö

15 Feb 2023

PONE-D-22-29767R1

Metabolomics of developmental changes in Triatoma sanguisuga gut microbiota

Dear Dr. Dumonteil:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Yara M. Traub-Csekö

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Rarefaction curves for individual samples.

    Curves indicate adequate sequencing depth for samples included in the analysis.

    (TIF)

    S2 Fig. Comparison of alfa and beta diversity of second and third stage nymphs.

    For alpha diversity, there was no significant difference in Shannon (t = 0.45, P = 0.65) and Chao1 indices (t = 1.34, P = 0.21) between second (N2) and third stage nymphs (N3). Beta diversity was also not different between N2 and N3 (PERMANOVA, F = 1.9; P = 0.09).

    (TIF)

    Attachment

    Submitted filename: Answers to reviewers.docx

    Data Availability Statement

    Raw sequence data are available in the NCBI SRA database under BioProject PRJNA892946, BioSamples SAMN31403430-.SAMN31403445.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES